Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-03-07
2006-03-07
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C549S471000, C562S512000, C562S587000, C548S335100, C548S469000, C548S470000, C546S339000, C514S469000, C514S416000, C514S415000, C514S396000, C514S354000, C514S571000
Reexamination Certificate
active
07008636
ABSTRACT:
This invention provides compounds of Formula I having the structureor a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
REFERENCES:
patent: 3394193 (1968-07-01), Reppe et al.
patent: 3666473 (1972-05-01), Colom et al.
patent: 3800051 (1974-03-01), Barnhart et al.
patent: 4117151 (1978-09-01), Descamps et al.
patent: 4147659 (1979-04-01), De Jonge et al.
patent: 4613611 (1986-09-01), Floyd, Jr. et al.
patent: 4808599 (1989-02-01), Dubroeucq et al.
patent: 5235064 (1993-08-01), Gapinski
patent: 5334598 (1994-08-01), Bagley et al.
patent: 5523302 (1996-06-01), Cain et al.
patent: 5596106 (1997-01-01), Cullinan et al.
patent: 5688821 (1997-11-01), Kees
patent: 5698574 (1997-12-01), Riedl et al.
patent: 5753687 (1998-05-01), Mjalli et al.
patent: 1 249 869 (1967-09-01), None
patent: 1 291 197 (1969-03-01), None
patent: 26 16 414 (1977-10-01), None
patent: 31110460 (1982-12-01), None
patent: 33 42 624 (1984-03-01), None
patent: 0 276 064 (1988-07-01), None
patent: 0 568 289 (1993-11-01), None
patent: 0 693 491 (1996-01-01), None
patent: 1 248 107 (1971-09-01), None
patent: 1 293 396 (1972-10-01), None
patent: 1 450 005 (1976-09-01), None
patent: 58150948 (1983-09-01), None
patent: 60172946 (1985-09-01), None
patent: 62036661 (1987-02-01), None
patent: 62036662 (1987-02-01), None
patent: 63161449 (1988-07-01), None
patent: 3247655 (1991-11-01), None
patent: 4016854 (1992-01-01), None
patent: 6348018 (1994-12-01), None
patent: WO 91/11909 (1991-08-01), None
patent: WO 94/22834 (1994-10-01), None
patent: WO 94/22835 (1994-10-01), None
patent: WO 96/08483 (1996-03-01), None
patent: WO 96/09818 (1996-04-01), None
patent: WO 96/34851 (1996-11-01), None
patent: WO 97/08934 (1997-03-01), None
patent: WO 97/21693 (1997-06-01), None
patent: WO 97/39748 (1997-10-01), None
Levin, P. et al.: Flash photolysis study of phenyl-substituted phenols, quinones, and corresponding free radicals.J.C.S. Perkins Transactions 2, vol. 9, pp. 1237-1239, 1981.
Kessler, M. et al.: An improved synthesis of the solvatochromic dye ET-30. Synthesis, vol. 8, pp. 635-636, 1988.
Compounds with RN 33661-81-3, 63671-76-1, 40410-91-1, 20104-41-0 and 186901-80-4. disclosed prior to 1995.
Ahmad et al., Biochemica et Biophysica Acta, 1995, 57-69, 1248.
Chang et al., Diabetes, 1983, 830-838, 32.
Coleman et al., Diabetologia, 1978, 141-148, 14.
DeFronzo et al., Diabetes Care, 1991, 173-194, 14(3).
Goldstein, Receptor, 1993, 1-15, 3.
Goldstein et al., Mol. and Cell. Biochem., 1992, 107-113, 109.
Goldstein, Cell. Biochem., 1992, 33-42, 48.
Haring, Diabetolgia, 1991, 848-861, 34.
Harris et al., Diabetes in America, 1985, 1-48, Ch. 29.
Jarrett, Diabetes/Metabolism Reviews, 1989, 547-558, 5(7).
Lanzetta et al., Analytical Biochem., 1979, 95-97, 100.
McGuire et al., Diabetes, Jul. 1991, 939-942, 40.
Meyerovitch et al., J. Clin. Invest., Apr. 1991, 1286-1294, 87.
Meyerovitch et al., J. Clin. Invest., Sep. 1989, 976-983, 84.
Mitsunobu, Synthesis, Jan. 1981, 1-28.
Nutaitis, Organic Preparations and Procedures Int., 1991, 403-411, 23(4).
Perlich et al., Synthesis, Feb. 1988, 142-144.
Phillon et al., 1986, 1477-1480, 27(13).
Pyorala et al., Diabetes/Metabolism Reviews. 1987, 463-524, 3(2).
Reaven et al., Amer. J. Med., 1976, 80-88, 60.
Stredy et al., Metabolism, 1995, 1074-1081, 44(8).
Stout et al., Metabolism, Dec. 1985, 7-12, 34(2) (Suppl. 1).
Zask et al., J. Med. Chem., 1990, 1418-1423, 33.
Chen et al., Indian J. Chem., Dec. 1996, 1304-1307, 35B.
d'Ischia et al., Tetrahedron, 1987, 431-434, 43(2).
Dryhurst et al., J. Am. Chem. Soc., 1989, 719-726, 111.
Guirguis et al., J. Prakt. Chem. Soc., 1990, 414-418, 332(3).
Guirguis et al., Liebigs Ann. Chem., 1986, 1003-1011.
Han et al., Tetrahedron Letter, 1990, 1181-1182, 31(8).
Hashem et al., J. Prakt. Chemie, 1977, 689-692, 319(4).
Konopelski et al., Synlett Letters, Jul. 1996, 609-611.
Kuroda et al., J. Org. Chem., 1994, 7353-7357, 59.
Kuroda et al., J. Chem. Soc., Chem. Commun., 1991, 1635-1636.
Lefker et al., Tetrahedron Letters, 1994, 5205-5208, 35(29).
Molina et al., Tetrahedron, 1994, 5027-5036, 50(17).
Molina et al., Tetrahedron Letters, 1993, 2809-2812, 34(17).
Napolitano et al., Tetrahedron, 1989, 6749-6760, 45(21).
Schuster et al., J. Org. Chem., 1988, 5819-5825, 53.
Buu-Hoi et al., J. Chem. Soc., 1957, 625-628.
Brown et al., J. Med. Chem., 1971, 84-85, 14(1).
Kimura et al., Tetrahedron Letters, 1995, 1079-1080, 36(7).
Schuster et al., J. Org. Chem., 1988, 5819-5825, 53.
Kano et al., Heterocycles, 1982, 1033-1037, 19(6).
Martin et al., J. Org. Chem., 1984, 2512-2513, 49.
Eckert et al., Arch. Pharm., 1982, 569-570, 315.
Goldenberg et al., Eur. J. Med. Chem., Chim. Ther., Jan.-Feb. 1977, 81-86, 12(1).
Artini et al., Arzneim-Forsch. (Drugs Res.), 1971, 30-36, 21(1).
Ayyangar et al., Synthesis, Apr. 1991, 322-324.
Darchen et al., J.C.S. Chem. Comm., 1976, 820.
DeCointet et al., Chimie Therapeutique, Sep.-Oct. 1973, 574-587, 5.
Hamacher, Arch. Pharmaz., 1975, 290-301, 308.
Massolina et al., Il Farmaco, 1990, 263-268, 45(2).
Miyaura et al., Synthetic Communications, 1981, 513-519, 11(7).
Barraclough et al, Arch Pharm., 1990, 507-512, 323.
Liebeskind et al., J. Org. Chem., 1990, 5359-5364, 55.
Toth, Liebigs Ann Chem., 1994, 685-688.
Watanabe et al., Chem. Abstracts, 1996, 124:116928s.
Abdurasuleva et al., Chem. Abstracts, 1965, 62:10356a.
Richter et al., 1967, 67:21652n.
Kryuchkova et al., Chem. Abstracts, 1961, 55:3488i.
Zavgorodini et al., Chem. Abstracts, 1962, 57:14982ia.
Boit, Beilstein Handbook of Org. Chem., 1966, 1374-1381, 1384, 1749, 3330-3339, 3361-3364, 4thed., 3rdSuppl., vol. VI.
Richter, Beilstein Handbook of Org. Chem., 1933, 183-185, 217, 218, 4thed., 1stSuppl., vols. XIII/XIV.
Luckenbach, Beilstein Handbook of Org. Chem., 1979, 2141-2126, 3268, 3271, 4thed., 4thSuppl., vol. VI.
Aldrich Catalog, 1996, p. 596.
Abdelkader, M. et al. : Synthesis and characterization of a stable poly(iminomethylene) with pendant phenoxyl radicals. Chem. Mater. vol. 3, pp. 598-602, 1991.
Potter, D. et al. : Identification of Acetaminophen polymerization products catalyzed by horseradish peroxidase. J. Biol. Chem. vol. 260, pp. 12174-12180, 1985.
Butera John A.
Caufield Craig E.
Graceffa Russell F.
Greenfield Alexander
Gundersen Eric G.
Aulakh Charanjit S.
Fish & Richardson P.C.
Wyeth
LandOfFree
2,3,5-substituted biphenyls useful in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3,5-substituted biphenyls useful in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3,5-substituted biphenyls useful in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3569172